Position in MRNA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,838,961
+$909,787 QoQ
Shares Held
83,378
-14.1% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#140
of 777 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Derivatives in MRNA
reported options exposure · as of Jun 30, 2026CallValue
$269,615,500
CallShares
3,850,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tidal Investments LLC holds $326,129,958 across 89 Biotechnology names. MRNA ranks #13 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
95,685 | $47,529,610 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
43,896 | $27,370,911 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
109,096 | $20,431,498 | |
| 4 | EXEL |
Exelixis, Inc.
|
375,316 | $20,420,943 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
190,305 | $14,895,171 | |
| 6 | INCY |
Incyte Corp
|
102,834 | $11,657,262 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,541 | $10,096,847 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
241,565 | $9,348,565 |
All Filings in MRNA
Export CSV
35 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $269,615,500 | 3,850,000 | Call | Sole | 2026-08-13 | |
| 2026-06-30 | $5,838,961 | 83,378 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,929,174 | 97,031 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $253,085,600 | 4,982,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $115,364,880 | 3,912,000 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $475,849 | 16,136 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $483,847 | 18,732 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $205,865,100 | 7,970,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $1,892,122 | 68,580 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $544,516 | 19,736 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $240,435 | 8,481 | Shares | Defined | 2025-05-14 | |
| 2025-03-31 | $1,459,458 | 51,480 | Call | Sole | 2025-05-14 | |
| 2024-12-31 | $7,683,816 | 184,796 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $1,252,389 | 30,120 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $14,000 | 1,750 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $451,770 | 6,760 | Call | Defined | 2024-11-25 | |
| 2024-09-30 | $688,615 | 10,304 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $280,250 | 2,360 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $1,752,749 | 14,760 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $226,972 | 2,130 | Call | Defined | 2024-05-16 | |
| 2024-03-31 | $2,265,571 | 21,261 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $1,240,539 | 12,474 | Shares | Sole | 2024-02-15 | |
| 2023-12-31 | $29,337 | 295 | Call | Defined | 2024-02-15 | |
| 2023-09-30 | $1,322,731 | 12,806 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,773,657 | 14,598 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,178,410 | 33,718 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,538,582 | 30,835 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $3,598,584 | 30,432 | Shares | Sole | 2022-11-23 | |
| 2022-06-30 | $4,015,942 | 28,113 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,254,649 | 24,699 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $4,449,475 | 17,519 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $5,968,793 | 15,509 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,571,386 | 10,943 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $469,848 | 3,588 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $285,725 | 2,735 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||